Medication Safety in Pregnancy Sickness

Why Medication Safety Matters in Pregnancy Sickness

If you are struggling with nausea and vomiting in pregnancy (NVP) or hyperemesis gravidarum (HG), you may be considering medication to help manage your symptoms. It is completely natural to have questions and concerns about taking any medication during pregnancy. You want to do the best for your baby, and the thought of taking drugs while pregnant can feel frightening.

The good news is that the medications most commonly prescribed for pregnancy sickness in the UK have been used for decades and have been studied in hundreds of thousands of pregnancies. The evidence overwhelmingly shows that these medications are safe and that the risks of untreated moderate-to-severe sickness — including dehydration, malnutrition, weight loss, electrolyte disturbances, and psychological harm — are far greater than the very small risks associated with anti-sickness medication.

This guide aims to give you clear, honest, evidence-based information about the medications available, so that you can have informed conversations with your healthcare provider and make decisions that are right for you. You deserve to understand the options and to feel confident in whatever choice you make.

Understanding Medication Categories in Pregnancy

In the UK, medications are not formally assigned letter-based pregnancy categories in the way they are in some other countries (such as the former FDA categories A, B, C, D, and X in the United States, which were retired in 2015). Instead, UK prescribers rely on several authoritative sources to assess the safety of medications in pregnancy:

Key UK Resources for Pregnancy Medication Safety

• British National Formulary (BNF): The BNF includes pregnancy and breastfeeding advice for every listed medication, based on available evidence and expert review. It is the primary reference for UK prescribers.
• UK Teratology Information Service (UKTIS): UKTIS provides specialist evidence-based assessments of drug exposures in pregnancy. Their patient-facing information is published through Bumps (Best Use of Medicines in Pregnancy) at medicinesinpregnancy.org.
• Summary of Product Characteristics (SmPC): The manufacturer's official product information, which includes a section on fertility, pregnancy, and lactation. Note that SmPCs are often overly cautious and may not reflect the totality of real-world evidence.
• RCOG Green-top Guidelines: The Royal College of Obstetricians and Gynaecologists publishes evidence-based clinical guidelines, including Green-top Guideline No. 69 on the management of NVP and HG.
• NICE Clinical Knowledge Summaries: Practical primary care guidance from the National Institute for Health and Care Excellence, including when and what to prescribe.

How Safety Is Assessed

Medication safety in pregnancy is assessed through a combination of evidence sources:

• Animal studies: Preclinical testing in animals provides initial safety signals, but results do not always translate directly to humans.
• Observational cohort studies: Large population-based studies that follow women who took a medication during pregnancy and compare outcomes to those who did not. These are the most important source of real-world safety data.
• Case-control studies: Studies that compare medication exposures in babies born with specific conditions versus those without.
• Pregnancy registries: Organised collections of data on medication exposures and outcomes, often run by pharmaceutical companies or academic institutions.
• Systematic reviews and meta-analyses: Studies that combine data from multiple individual studies to provide a more robust overall picture.
• Decades of clinical experience: For older medications like cyclizine and promethazine, there are decades of widespread use providing a wealth of reassuring real-world data.

First-Line Medications: Pyridoxine (Vitamin B6) and Doxylamine

Pyridoxine (Vitamin B6)

Pyridoxine, also known as vitamin B6, is often recommended as a first step in managing mild pregnancy nausea. It is a water-soluble vitamin that plays a role in numerous metabolic processes, and supplementation has been shown to reduce the severity of nausea (though not necessarily vomiting) in some women.

• Typical dose: 10–25mg three times daily (up to 200mg per day is considered safe, but higher doses should be supervised)
• How it works: The exact mechanism is not fully understood, but pyridoxine is involved in amino acid metabolism and neurotransmitter synthesis, which may help modulate the nausea response
• Evidence: A Cochrane review found modest evidence that vitamin B6 reduces the severity of nausea but had limited effect on vomiting episodes. It is most helpful for mild symptoms.
• Safety: Excellent safety profile. Pyridoxine is a vitamin and is not associated with any teratogenic risk at recommended doses. Very high doses (over 500mg/day for prolonged periods) can cause peripheral neuropathy, but this is not relevant at antiemetic doses.
• Availability: Available over the counter from pharmacies. Not always routinely prescribed by GPs as a first step.
• Limitations: Generally insufficient for moderate-to-severe NVP or HG. Should not be used as the sole treatment if symptoms are significantly affecting quality of life, hydration, or nutrition.

Doxylamine

Doxylamine is a first-generation antihistamine (H1 receptor antagonist) that has strong antiemetic properties. In combination with pyridoxine, it forms the basis of first-line treatment for pregnancy sickness in North America, where a branded combination product (Diclegis/Diclectin) is widely prescribed.

• Typical dose: 12.5–25mg at bedtime, or 12.5mg twice daily (morning and bedtime) combined with pyridoxine 10–25mg
• How it works: Doxylamine blocks histamine H1 receptors in the vomiting centre of the brain. It also has anticholinergic properties that reduce nausea signals.
• Evidence: The doxylamine-pyridoxine combination is the most extensively studied antiemetic in pregnancy, with safety data from over 200,000 exposures. Multiple systematic reviews confirm no increase in birth defect rates.
• Safety: One of the best-studied medications in pregnancy. The original combination product (Bendectin/Debendox) was withdrawn from market in the 1980s due to litigation pressure despite no evidence of harm — a decision widely regarded as one of the worst outcomes of unfounded medication safety scares in history.
• UK availability: Doxylamine is not as commonly prescribed in the UK as in North America. It is available as an over-the-counter sleep aid (Sominex) but is not licensed specifically as an antiemetic in the UK. Some UK clinicians do prescribe it off-label, particularly when other first-line options have failed.
• Side effects: Drowsiness is the main side effect, which can be managed by taking the larger dose at bedtime. Dry mouth and constipation may also occur.

Antihistamine Antiemetics: Cyclizine and Promethazine

Antihistamine medications are among the most commonly prescribed first-line antiemetics for pregnancy sickness in the UK. They work by blocking histamine H1 receptors in the vomiting centre of the brain and also have anticholinergic effects that help reduce nausea.

Cyclizine

Cyclizine is one of the most widely used antiemetics in UK obstetric practice and is often the first medication offered for pregnancy sickness.

• Dose: 50mg up to three times daily, taken orally, by intramuscular injection (IM), or intravenously (IV)
• How it works: Blocks histamine H1 receptors and has anticholinergic activity, reducing signals to the vomiting centre
• Safety evidence: Extensive use over several decades. Large cohort studies show no increase in congenital malformation rates. The safety profile is very reassuring.
• Side effects: Drowsiness (usually mild and often diminishes with continued use), dry mouth, blurred vision, constipation. Some women find the drowsiness helpful for sleeping through the worst of their nausea.
• NHS availability: Widely available on NHS prescription. Also available in injectable form for hospital or ambulatory use.
• Breastfeeding: Compatible. Small amounts pass into breast milk but no adverse effects in breastfed infants have been reported.

Promethazine

Promethazine is another antihistamine with a long history of use in pregnancy. It is more sedating than cyclizine, which can be an advantage or disadvantage depending on individual circumstances.

• Dose: 12.5–25mg up to four times daily, taken orally or by intramuscular injection
• How it works: Similar to cyclizine but with stronger sedative properties. Also a phenothiazine derivative with dopamine-blocking activity.
• Safety evidence: Long safety record with inclusion in multiple meta-analyses showing no increased teratogenic risk.
• Side effects: Significant drowsiness (more than cyclizine), dry mouth, dizziness, blurred vision. The sedation may be helpful if nausea is worse at night or if insomnia is a problem.
• NHS availability: Available on NHS prescription. Also available over the counter as Phenergan (10mg and 25mg tablets) for short-term use, though pharmacists may be reluctant to sell it to visibly pregnant women without a prescription.
• Breastfeeding: Compatible, but observe the infant for drowsiness due to the sedative properties.

Anti-emetics: Prochlorperazine and Metoclopramide

Prochlorperazine (Stemetil/Buccastem)

Prochlorperazine is a phenothiazine that works primarily by blocking dopamine receptors in the chemoreceptor trigger zone. It is widely used in UK obstetric practice.

• Dose: 5–10mg orally up to three times daily, or 3–6mg buccally (dissolved between the upper lip and gum) twice daily. Can also be given by intramuscular injection.
• How it works: Blocks dopamine D2 receptors in the chemoreceptor trigger zone, which is one of the key areas of the brain involved in triggering nausea and vomiting.
• Safety evidence: Widely used in pregnancy with large epidemiological studies showing no significant increase in malformation risk. Decades of clinical experience support its safety.
• Side effects: Drowsiness, dry mouth, dizziness. Rare but important: extrapyramidal side effects (involuntary muscle movements, restlessness, muscle stiffness) — these are uncommon but can be distressing. If you experience unusual muscle movements or stiffness, contact your healthcare provider.
• Buccal formulation advantage: The buccal tablet (Buccastem M) dissolves against the gum and is absorbed through the lining of the mouth. This is particularly useful if you cannot keep oral tablets down due to vomiting. It is available over the counter for nausea, though not specifically marketed for pregnancy use.
• NHS availability: Widely available on NHS prescription in oral, buccal, and injectable forms.
• Breastfeeding: Compatible. Monitor the infant for drowsiness or irritability.

Metoclopramide (Maxolon)

Metoclopramide is a dopamine antagonist with prokinetic (gut-motility-enhancing) properties. It works both centrally (in the brain) to reduce nausea and peripherally (in the gut) to speed gastric emptying.

• Dose: 10mg up to three times daily, taken orally, by intramuscular injection, or intravenously. Important: The MHRA recommends limiting continuous use to a maximum of 5 days due to the risk of extrapyramidal side effects and tardive dyskinesia (this is a general recommendation, not specific to pregnancy).
• How it works: Blocks dopamine D2 receptors centrally and enhances gastric motility, helping food and fluids move through the stomach more quickly. This dual action can be particularly helpful when gastric stasis (slow stomach emptying) is contributing to nausea.
• Safety evidence: A large Israeli cohort study covering over 80,000 exposures found no increased malformation risk. This is one of the largest safety studies for any medication in pregnancy.
• Side effects: Drowsiness, restlessness, diarrhoea. The main concern is extrapyramidal side effects (particularly in young women, who are the demographic most likely to need it in pregnancy). These are rare but can include acute dystonia (sudden muscle spasms), akathisia (restlessness), and, with prolonged use, tardive dyskinesia (involuntary facial movements).
• The 5-day rule: The MHRA restriction to 5 days of continuous use can be problematic for pregnancy sickness, which typically lasts weeks or months. In practice, many specialists use metoclopramide for longer periods in pregnancy when the benefit clearly outweighs the risk, or use it in short courses interspersed with other antiemetics. Discuss this with your doctor.
• NHS availability: Widely available on NHS prescription.
• Breastfeeding: Compatible. Present in breast milk in small quantities. May increase prolactin and milk supply.

Ondansetron (Zofran): A Detailed Look

Ondansetron is a 5-HT3 (serotonin) receptor antagonist that was originally developed for chemotherapy-induced nausea and vomiting. It has become one of the most important medications in the management of moderate-to-severe NVP and hyperemesis gravidarum, and many women describe it as the medication that made the difference between being able to continue their pregnancy and not.

How Ondansetron Works

Ondansetron blocks serotonin receptors (5-HT3 receptors) both in the gut and in the vomiting centre of the brain. Serotonin plays a major role in triggering nausea and vomiting, and blocking these receptors is a highly effective antiemetic strategy. It works through a completely different mechanism from antihistamines and dopamine antagonists, which is why it can be effective when other medications have failed.

Dosing and Administration

• Oral dose: 4–8mg up to three times daily. Tablets should be swallowed whole with water. An orodispersible (melt-on-the-tongue) formulation is available, which is useful if swallowing tablets triggers vomiting.
• IV dose: 4–8mg by slow intravenous injection, used in hospital or ambulatory settings when oral administration is not possible.
• Onset of action: Oral: within 30 minutes. IV: within 5 minutes.

The Safety Evidence: What the Research Says

Ondansetron has been the subject of extensive research in pregnancy. Here is what the key studies show:

• Danish cohort study (Pasternak et al., 2013, NEJM): Studied over 600,000 pregnancies and found no overall increase in malformation rates with first-trimester ondansetron exposure.
• US cohort study (Huybrechts et al., 2018, JAMA): The largest study to date, involving over 88,000 ondansetron-exposed pregnancies. Found a small, statistically significant increase in cleft palate risk: from approximately 11.1 per 10,000 unexposed pregnancies to approximately 14.0 per 10,000 exposed pregnancies.
• What this means in absolute terms: An additional 3 cases of cleft palate per 10,000 pregnancies exposed to ondansetron. Another way of expressing this: if 3,300 women take ondansetron in the first trimester, approximately one additional baby would be born with a cleft palate compared to if none of those women had taken it.
• Cardiac malformations: No increase in cardiac defects was found, contradicting earlier, smaller studies that had raised this concern.
• European Medicines Agency (EMA) position: The EMA reviewed the data in 2019 and advised that ondansetron should not be used in the first trimester. However, this recommendation is considered overly cautious by many UK specialists.
• RCOG position: The RCOG supports the use of ondansetron for pregnancy sickness when other medications have not provided adequate control, recognising that the very small potential risk must be weighed against the definite harms of untreated severe sickness.

Ondansetron Side Effects

• Constipation: This is the most common side effect and can be significant. Many women with pregnancy sickness already experience constipation, and ondansetron can make it worse. Adequate fluid intake, dietary fibre, and osmotic laxatives (such as lactulose or macrogol) may be needed.
• Headache: Some women experience headaches, usually mild.
• QT prolongation: At high doses or in combination with other QT-prolonging drugs, ondansetron can affect the heart rhythm. This is mainly a concern at doses higher than those used for pregnancy sickness. An ECG may be recommended if you are on other medications that affect heart rhythm.
• Fatigue and dizziness: Less common than with antihistamine antiemetics.

Corticosteroids for Severe Hyperemesis Gravidarum

Corticosteroids (such as hydrocortisone and prednisolone) are reserved for the most severe cases of hyperemesis gravidarum that have not responded to standard antiemetic therapy. They are not a first-line treatment but can be highly effective when other options have been exhausted.

When Are Corticosteroids Used?

Corticosteroids are typically considered when a woman has:

• Failed to respond to adequate trials of two or more antiemetic medications in combination
• Required multiple hospital admissions for IV fluids
• Continued to lose weight despite treatment
• Developed significant complications such as electrolyte disturbances or is unable to function at all

How They Are Given

• Initial dose: Hydrocortisone 100mg intravenously (IV) twice daily for 2–3 days in hospital
• Conversion to oral: Once vomiting improves, switch to prednisolone 40–50mg orally once daily
• Tapering: The dose is gradually reduced (tapered) over 2–3 weeks. Stopping corticosteroids abruptly can cause symptoms to rebound and may suppress the adrenal glands. Your doctor will give you a specific tapering schedule.
• Repeat courses: Some women need more than one course of corticosteroids during their pregnancy.

Safety Considerations

• First trimester: There is a possible small association between high-dose first-trimester corticosteroid use and cleft palate (similar in magnitude to the possible risk with ondansetron — approximately 3 additional cases per 10,000 exposures). For this reason, corticosteroids are ideally avoided before 10 weeks of gestation if possible, but may be used if the clinical situation demands it.
• Later in pregnancy: The cleft palate concern applies only to the first trimester. Corticosteroids are widely and safely used later in pregnancy for various conditions (such as promoting fetal lung maturity before preterm birth).
• Gestational diabetes: Corticosteroids can raise blood sugar levels, and prolonged use may increase the risk of gestational diabetes. Blood sugar monitoring is recommended during treatment.
• Adrenal suppression: Prolonged use can suppress the body’s natural cortisol production. This is managed through careful dose tapering.
• Other side effects: Insomnia, increased appetite (which can actually be helpful in HG), mood changes, indigestion. Most side effects are manageable and resolve after the course is completed.

IV Fluids and TPN: When Oral Medication Fails

When you are unable to keep any oral medication (or fluids) down, alternative routes of administration become essential. This section covers what to expect if you need intravenous (IV) treatment or, in rare severe cases, total parenteral nutrition (TPN).

Intravenous (IV) Fluids

IV fluid therapy replaces the fluid and electrolytes lost through vomiting and poor oral intake. It can be given in hospital as an inpatient, or increasingly through ambulatory (day-case) services where you attend a hospital or clinic for treatment and then go home.

• What fluids are used: Usually normal saline (0.9% sodium chloride) or Hartmann’s solution, which replaces the salts your body has lost. Dextrose (sugar) solutions may be added once rehydration is established.
• How long does it take: A typical session involves 1–2 litres of fluid given over 2–4 hours. You may need daily sessions for several days, or less frequently depending on your clinical needs.
• Medications given with IV fluids: Anti-sickness medications (such as cyclizine, metoclopramide, or ondansetron) can be given through the IV line, which is useful if you cannot tolerate oral tablets. Vitamin supplements, including thiamine (vitamin B1), may also be given intravenously.
• Potassium replacement: If your blood potassium level is low (a common consequence of prolonged vomiting), potassium chloride will be added to your IV fluids.

Ambulatory (Day-Case) IV Treatment

Many hospitals now offer ambulatory or day-case IV rehydration services, which allow you to receive IV fluids, medication, and monitoring without being admitted overnight. This can be a much more comfortable option for many women and may be available through:

• Dedicated hyperemesis or pregnancy assessment day units
• Gynaecology assessment units (GAU) or early pregnancy units (EPU)
• Medical assessment units
• Some GP surgeries with the appropriate facilities

Nasogastric (NG) and Nasojejunal (NJ) Tube Feeding

In severe, prolonged cases where oral intake remains impossible despite IV fluids and medication, tube feeding may be considered. A thin, flexible tube is passed through the nose into the stomach (nasogastric) or small intestine (nasojejunal) to deliver liquid nutrition directly. This is uncommon and is usually managed by a specialist team including a dietitian.

Total Parenteral Nutrition (TPN)

TPN involves delivering all necessary nutrients directly into the bloodstream through a central venous catheter (a line placed into a large vein, usually in the neck or chest). This completely bypasses the digestive system.

• When is TPN used: TPN is genuinely a last resort, used only when all other methods of nutrition have failed and there is a significant risk of malnutrition to the mother or baby.
• Risks: TPN carries significant risks including line infection (which can be life-threatening), blood clots, liver complications, and metabolic disturbances. These risks mean it is only used when the alternative — continued starvation — is worse.
• How long: TPN is used for as short a period as possible, with the goal of transitioning back to enteral (gut-based) nutrition as soon as it can be tolerated.

Complementary Approaches: Ginger, Acupressure, and P6 Wristbands

Many women prefer to try non-pharmaceutical approaches first, or to use them alongside prescribed medication. The following complementary therapies have some evidence base and are considered safe in pregnancy.

Ginger

Ginger (Zingiber officinale) is the most studied complementary therapy for pregnancy nausea. It has been used for centuries across many cultures for its anti-nausea properties.

• How it works: Ginger contains compounds (gingerols and shogaols) that are thought to act on serotonin receptors in the gut and may have direct effects on gastric motility.
• Evidence: Several randomised controlled trials and systematic reviews have found ginger to be modestly effective for reducing nausea severity, particularly in mild NVP. A Cochrane review concluded that ginger may be helpful but noted that the quality of evidence was limited.
• Recommended dose: 250mg of dried ginger root four times daily (total 1g/day), or equivalent in fresh ginger, ginger tea, or ginger biscuits. Standardised supplements from a reputable source are preferable to ensure consistent dosing.
• Safety: Generally considered safe at recommended doses. Some theoretical concern about effects on blood clotting at very high doses, but no adverse effects have been reported at antiemetic doses.
• Limitations: The effect is modest and is unlikely to be sufficient for moderate-to-severe NVP. If ginger is not providing adequate relief, do not persist with it — move to pharmacological treatment.

Acupressure and P6 (Nei Guan) Wristbands

Acupressure involves applying pressure to specific points on the body. The P6 (Nei Guan or Pericardium 6) point, located on the inner wrist approximately three finger-widths below the wrist crease between the two tendons, has been traditionally used in Chinese medicine for nausea relief.

• How to use: Sea-Bands and similar wristbands apply continuous gentle pressure to the P6 point. Wear them on both wrists with the button pressing firmly on the point.
• Evidence: Studies show mixed results. Some randomised trials have found acupressure to be more effective than a placebo wristband, while others found no significant difference. The effect, if present, appears to be modest.
• Safety: Completely safe with no known side effects. The worst outcome is that they do not help.
• Cost and availability: Sea-Bands are available from pharmacies and supermarkets for a few pounds. They can be used alongside any medication.

Acupuncture

Acupuncture involves the insertion of fine needles at specific points on the body by a trained practitioner.

• Evidence: The evidence for acupuncture in pregnancy sickness is mixed. Some studies report benefit, but a Cochrane review found insufficient evidence to draw firm conclusions.
• Safety: Safe when performed by a qualified, registered practitioner who has experience treating pregnant women. Ensure your acupuncturist is a member of the British Acupuncture Council or equivalent professional body.
• Practical considerations: Requires multiple sessions, which may be difficult if you are severely unwell. Cost can be a barrier as NHS-funded acupuncture is not widely available for pregnancy sickness.

Medication Comparison Table

The following table provides an at-a-glance comparison of the main medications used for pregnancy sickness in the UK. Use it as a reference when discussing options with your healthcare provider.

Medication	Type	Evidence Level	Common Side Effects	NHS Available	Breastfeeding Safe
Pyridoxine (B6)	Vitamin supplement	Moderate (Cochrane review: modest benefit for nausea)	None at recommended doses	Yes (also OTC)	Yes
Doxylamine	Antihistamine (H1)	High (200,000+ exposures studied; multiple systematic reviews)	Drowsiness, dry mouth, constipation	Off-label only	Yes (monitor for drowsiness)
Cyclizine	Antihistamine (H1)	High (decades of use; large cohort studies reassuring)	Mild drowsiness, dry mouth, blurred vision	Yes	Yes
Promethazine	Antihistamine / phenothiazine	High (long safety record; multiple meta-analyses)	Significant drowsiness, dry mouth, dizziness	Yes (also OTC as Phenergan)	Yes (monitor for drowsiness)
Prochlorperazine	Dopamine antagonist	High (large epidemiological studies; decades of use)	Drowsiness, dry mouth; rare extrapyramidal effects	Yes (buccal form also OTC)	Yes
Metoclopramide	Dopamine antagonist / prokinetic	High (80,000+ exposures in Israeli cohort study)	Drowsiness, restlessness; rare extrapyramidal effects; MHRA 5-day limit	Yes	Yes
Ondansetron	5-HT3 antagonist	High (88,000+ exposures; possible very small cleft palate risk)	Constipation, headache; rare QT prolongation	Yes	Likely (limited data)
Domperidone	Dopamine antagonist / prokinetic	Moderate (less human pregnancy data; no teratogenicity signal)	Headache, dry mouth; MHRA cardiac warnings	Yes	Yes (used to promote lactation)
Corticosteroids	Glucocorticoid	Moderate (reserved for refractory HG; possible small cleft palate risk in 1st trimester)	Insomnia, increased appetite, mood changes, raised blood sugar	Yes (specialist initiated)	Yes (prednisolone)
Ginger	Herbal supplement	Low–Moderate (Cochrane review: modest benefit; limited trial quality)	Heartburn, mild gastrointestinal upset at high doses	No (OTC supplement)	Yes

Timing and Dosing Considerations

Getting the timing and dosing of your medication right can make a significant difference to how well it works. Here are some practical considerations:

When to Take Your Medication

• Preventive dosing: Anti-sickness medication works best when taken before nausea becomes severe, rather than waiting until you are already vomiting. Think of it like pain relief — it is easier to stay ahead of symptoms than to catch up.
• Bedtime dosing: If your nausea is worst first thing in the morning, taking a dose of medication at bedtime (or keeping medication by your bedside to take before you get up) can help you start the day with some protection. Promethazine and doxylamine are particularly suited to bedtime dosing due to their sedative effects.
• Regular dosing: Taking medication at regular intervals throughout the day (as prescribed) maintains a consistent level in your bloodstream and provides more reliable symptom control than taking it only when symptoms flare.
• Before meals: Some women find it helpful to take their antiemetic 30 minutes before attempting to eat, giving the medication time to take effect.
• If you vomit after taking a tablet: If you vomit within 30 minutes of taking an oral tablet, the medication may not have been absorbed. You can usually take another dose. If you vomit more than 30 minutes after taking a tablet, the medication has likely been at least partially absorbed. Ask your pharmacist or doctor for specific guidance on your medication.

Routes of Administration

If you cannot keep tablets down, there are alternative ways to take anti-sickness medication:

• Buccal tablets: Prochlorperazine (Buccastem) dissolves against the gum and is absorbed through the mouth lining, bypassing the stomach entirely.
• Orodispersible tablets: Ondansetron melts are placed on the tongue and dissolve rapidly. They are absorbed partly through the oral mucosa and partly through the gut.
• Intramuscular (IM) injection: Cyclizine, promethazine, prochlorperazine, and metoclopramide can all be given by injection into the muscle. This can be administered at a GP surgery, hospital, or by a district nurse.
• Intravenous (IV) injection: Most antiemetics can be given directly into a vein in a hospital or ambulatory care setting.
• Suppositories: Some antiemetics are available as suppositories (inserted rectally), though this route is less commonly used in the UK for pregnancy sickness.

Dose Adjustments

• Starting low: Your doctor may start you on the lower end of the dose range and increase if needed, to minimise side effects while finding the effective dose for you.
• Maximum doses: Each medication has a maximum daily dose. If you are at the maximum dose and still symptomatic, the next step is usually to add a second medication from a different class, not to exceed the maximum of the first.
• Reducing doses: As your symptoms improve (often in the second trimester), your doctor may suggest gradually reducing the dose. Do this slowly — cutting medication suddenly can cause symptoms to rebound. Many women find they need a lower maintenance dose rather than stopping completely.
• Restarting medication: If symptoms return after reducing or stopping medication, resume it promptly. There is no "badge of honour" for managing without medication if you are suffering.

Safety Data: What the Research Says

Understanding the safety evidence behind pregnancy medications can help you feel more confident in your treatment decisions. Here is a summary of what the major studies tell us about the medications most commonly used for pregnancy sickness.

The Reassuring Big Picture

The baseline risk of any major birth defect in any pregnancy (with or without medication) is approximately 2–3%. This is the background rate that applies to every baby regardless of what the mother does or does not take. Against this background, the first-line antiemetics used for pregnancy sickness have been shown in large studies to not increase the overall malformation rate. This is powerful, reassuring evidence.

Key Studies at a Glance

Medication	Key Study	Number of Exposures Studied	Finding
Doxylamine + Pyridoxine	Multiple meta-analyses (1960s–present)	200,000+	No increase in birth defects. One of the most thoroughly studied drug combinations in pregnancy.
Cyclizine	Large UK/European cohort studies	Tens of thousands (decades of use)	No increase in congenital malformations. Very reassuring long-term safety record.
Metoclopramide	Matok et al., 2009 (Israel)	81,703 exposed pregnancies	No increased risk of major malformations, low birth weight, or preterm delivery.
Ondansetron	Huybrechts et al., 2018 (JAMA)	88,467 exposed pregnancies	Possible very small increase in cleft palate (~3 per 10,000). No increase in cardiac defects.
Prochlorperazine	Multiple epidemiological studies	Tens of thousands (decades of use)	No significant increase in malformation risk.
Corticosteroids	Park-Wyllie et al., 2000 (meta-analysis)	Multiple studies combined	Possible small increase in cleft palate with first-trimester high-dose exposure (~3 per 10,000). No increase with later use.

Medications to Avoid in Pregnancy

While many medications are safe in pregnancy, some should be avoided. The following are medications sometimes used for nausea in non-pregnant patients that should not be used during pregnancy:

Medication	Why It Should Be Avoided	Safer Alternative
Granisetron (IV formulation)	Limited pregnancy safety data compared to ondansetron. Ondansetron is the preferred 5-HT3 antagonist in pregnancy.	Ondansetron
Nabilone (synthetic cannabinoid)	Insufficient safety data in pregnancy. Potential concerns about fetal neurodevelopment.	Standard antiemetics as per RCOG guidelines
Cannabis / CBD products	Associated with low birth weight and possible neurodevelopmental effects. Not regulated for consistency or purity.	Prescribed antiemetics
Methotrexate	Potent teratogen. Must be stopped well before conception. Sometimes used for conditions that co-exist with pregnancy sickness.	Discuss alternatives with your specialist
Misoprostol	Can cause uterine contractions and is used as an abortifacient. Never use for nausea in pregnancy.	Standard antiemetics
High-dose vitamin A supplements	Teratogenic at high doses. Some “natural” nausea remedies contain vitamin A. Always check supplement ingredients.	Standard pregnancy multivitamin with safe vitamin A levels
Bismuth subsalicylate (Pepto-Bismol)	Contains salicylate (aspirin-like compound) which should be avoided in pregnancy, particularly in the third trimester. The bismuth component may also pose risks.	Prescribed antiemetics; antacids if reflux is contributing

Talking to Your GP About Medication Concerns

Having an open, honest conversation with your GP about medication for pregnancy sickness is important. Here are some tips and phrases that may help:

Preparing for Your Appointment

• Write down your symptoms: Note how many times a day you are vomiting, how many hours you feel nauseous, whether you can keep any food or fluid down, and how your symptoms are affecting your daily life (work, childcare, mobility, mental health).
• Record your weight: If you know your pre-pregnancy weight, note how much you have lost. Weight loss of 5% or more is clinically significant.
• List what you have tried: Document any remedies or medications you have already tried and whether they helped.
• Bring information: If you are concerned your GP may not be familiar with the latest guidelines, consider printing the RCOG Green-top Guideline No. 69 summary or information from the Pregnancy Sickness Support website to share.

Helpful Phrases to Use

• “My nausea and vomiting are severely affecting my ability to function. I need medical treatment.”
• “I understand there are antiemetic medications that are considered safe in pregnancy. Can we discuss my options?”
• “I have lost [X]% of my body weight and am unable to keep fluids down. I am worried about dehydration.”
• “I have already tried [ginger/wristbands/dietary changes] and they are not providing sufficient relief. What medication can you prescribe?”
• “I am aware that the RCOG guidelines recommend early antiemetic treatment for pregnancy sickness. Could we follow that approach?”
• “My current medication is not working well enough. Can we add a second medication or try a different one?”

If Your GP Is Reluctant to Prescribe

Unfortunately, some women encounter GPs who are reluctant to prescribe antiemetics in pregnancy, either due to unfounded safety concerns or a belief that pregnancy sickness is “normal” and should be endured. If this happens to you:

• Ask to see a different GP at the same practice. GPs have varying levels of expertise in this area.
• Request a referral to an obstetrician or the hospital’s pregnancy assessment unit.
• Share the guidelines: Politely point to the RCOG and NICE guidelines that recommend early pharmacological treatment.
• Contact the Pregnancy Sickness Support helpline on 024 7569 0504 for advice on how to advocate for yourself.
• If you are acutely unwell, attend A&E. You should not be left to deteriorate because of a prescribing disagreement in primary care.
• Consider a formal complaint if you feel your care has been inadequate. Every woman has the right to evidence-based treatment.

What to Do if Medication Is Not Working

If your current medication is not adequately controlling your symptoms, do not accept this as the best that can be done. There are many strategies your healthcare provider can use to improve your symptom control:

Step Up the Treatment

• Switch medication: If one antiemetic is not effective, try another from a different drug class. For example, if cyclizine (antihistamine) is not helping, try prochlorperazine (dopamine antagonist) or ondansetron (5-HT3 antagonist).
• Combine medications: Using two or more antiemetics from different classes together is a well-established approach. For example, cyclizine plus ondansetron, or prochlorperazine plus metoclopramide.
• Increase the dose: If you are on a low dose and tolerating the medication, your doctor may increase it to the maximum recommended dose.
• Change the route: If you cannot keep oral tablets down, switch to buccal, orodispersible, injectable, or IV formulations.
• Add corticosteroids: If standard antiemetics in combination are not sufficient, corticosteroids may be the next step.
• Regular IV fluids: If dehydration is exacerbating your symptoms, scheduled ambulatory IV fluid sessions can help break the cycle.

When to Seek Urgent Help

Go to A&E or contact your maternity assessment unit immediately if you experience any of the following:

• Unable to keep any fluids down for more than 12 hours
• Very dark urine or not passing urine for more than 8 hours
• Dizziness or fainting when standing up
• Rapid heartbeat that does not settle with rest
• Blood in your vomit
• Severe abdominal pain
• Confusion, blurred vision, or unsteadiness (possible signs of Wernicke’s encephalopathy)
• Thoughts of harming yourself or not wanting to continue living
• Feeling so desperate that you are considering terminating a wanted pregnancy

The Emotional Aspects of Taking Medication in Pregnancy

The decision to take medication during pregnancy is not just a medical one — it is deeply emotional. Many women experience a complex mix of feelings, and it is important to acknowledge and address these rather than dismiss them.

Common Feelings

• Guilt: “I should be able to cope without medication.” This is perhaps the most common feeling. Society often sends the message that pregnancy discomfort should be endured silently. But pregnancy sickness is a medical condition, and treating it is responsible, not irresponsible.
• Fear: “What if the medication harms my baby?” This fear is completely understandable. Every mother wants to protect her child. But the evidence shows that the commonly used antiemetics are safe, and that untreated severe sickness carries real risks of its own.
• Shame: “Other women seem to manage without medication.” Every pregnancy is different. You do not know what other women are experiencing or how they are coping. Comparing yourself to others is neither fair nor helpful.
• Relief: When medication works, the relief can be overwhelming. Many women describe the moment a medication finally controlled their nausea as life-changing. This relief is nothing to feel guilty about.
• Anger: “Why did I have to fight to get this medication?” Some women feel angry that they had to advocate so hard for treatment that should have been offered earlier. This anger is valid.
• Grief: Pregnancy sickness can rob you of the pregnancy experience you imagined. You may grieve the loss of that imagined experience. This is a real loss and it is okay to feel sad about it.

Coping with Medication Anxiety

• Get the facts: Understanding the actual evidence (as outlined in this guide) can be enormously reassuring. Knowledge reduces fear.
• Talk to your healthcare provider: Ask them to explain the risks and benefits in absolute terms. A good conversation about the evidence can transform your confidence in your treatment decision.
• Read patient information leaflets from reliable sources: The Bumps (Best Use of Medicines in Pregnancy) website at medicinesinpregnancy.org provides excellent, evidence-based leaflets written for patients.
• Connect with other women: Hearing from women who have taken the same medication and had healthy babies can be deeply reassuring. The Pregnancy Sickness Support forum and helpline can connect you with others who have been through it.
• Consider counselling: If medication anxiety is severe, a few sessions with a counsellor or psychologist can help you work through your feelings and make a decision you feel at peace with.
• Give yourself permission: Permission to take medication. Permission to feel better. Permission to not be a martyr. You are not a bad mother for taking prescribed medication for a medical condition. You are a mother who is looking after herself so she can look after her baby.

Frequently Asked Questions